The development of androgen-independent prostate cancer

B J Feldman1, D Feldman

  • 1Department of Medicine, Stanford University School of Medicine, California 94305-5103, USA. feldman@cmgm.stanford.edu

Nature Reviews. Cancer
|March 20, 2002
PubMed

Insights

Androgen ablation therapy initially treats prostate cancer, but cancers can become androgen-independent. Understanding this transition is key to developing new therapies for advanced prostate cancer.

Area of Science:

  • Oncology
  • Endocrinology
  • Cancer Biology

Background:

  • Prostate cancers rely on androgens for growth.
  • Androgen ablation therapy causes initial tumor regression.
  • Some advanced prostate cancers develop androgen independence, resisting treatment.

Purpose of the Study:

  • Investigate the mechanisms driving androgen independence in prostate cancer.
  • Identify pathways crucial for the development of treatment-resistant prostate cancer.
  • Lay the groundwork for novel therapeutic strategies against advanced prostate cancer.

Main Methods:

  • This study focuses on the molecular pathways involved in prostate cancer progression.
  • The research predicts key mechanisms leading to androgen independence.
  • Further experimental validation is implied but not detailed.

Main Results:

  • The study hypothesizes the pathways leading to androgen independence.
  • Understanding these pathways is crucial for therapeutic development.
  • The exact molecular findings are not detailed in the abstract.

Conclusions:

  • Elucidating the pathways of androgen independence is critical.
  • This knowledge is essential for developing effective treatments for untreatable prostate cancers.
  • Future research will focus on targeting these identified pathways.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...